Ogorek Anthony Joseph’s DexCom DXCM Stock Holding History

Ogorek Anthony Joseph’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	–	–	653
2025 Q3	$0	Sell	2 -2	-50%	-$158	﹤0.01%	653
2025 Q2	$0	Hold	4	–	–	﹤0.01%	644
2025 Q1	$0	Buy	+4	New	+$326	﹤0.01%	638

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ogorek Anthony Joseph's DXCM Position: Q4 2025 in Review

Ogorek Anthony Joseph sold out of DexCom (DXCM) in Q4 2025, closing a stake of 2 shares.

Ogorek Anthony Joseph first reported a position in DXCM in Q1 2025 and held it in 3 quarters. The position peaked at $0 in Q3 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Ogorek Anthony Joseph reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Ogorek Anthony Joseph sold 2 DexCom shares in Q4 2025.
Ogorek Anthony Joseph first reported a position in DexCom in Q1 2025 and held it in 3 quarters.
Ogorek Anthony Joseph's DexCom position peaked at $0 in Q3 2025.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Ogorek Anthony Joseph's 13F filing for Q4 2025, filed 23 Jan 2026.